4/A//SEC Filing
Stanker James H 4/A
Accession 0001567619-22-018275
CIK 0001533743other
Filed
Oct 4, 8:00 PM ET
Accepted
Oct 5, 4:40 PM ET
Size
5.8 KB
Accession
0001567619-22-018275
Insider Transaction Report
Form 4/AAmended
Stanker James H
Chief Financial Officer
Transactions
- Award
Restricted Stock Units
2022-09-30−12,950→ 339,663 totalExercise: $0.00→ Common Stock (12,950 underlying)
Footnotes (2)
- [F1]Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon the earliest of: termination of employment; the third anniversary of the award date; a change of control; or the reporting person's death.
- [F2]Previous filing inadvertently underreported derivative securities beneficially owned by the reporting person.
Documents
Issuer
Processa Pharmaceuticals, Inc.
CIK 0001533743
Entity typeother
Related Parties
1- filerCIK 0001681718
Filing Metadata
- Form type
- 4/A
- Filed
- Oct 4, 8:00 PM ET
- Accepted
- Oct 5, 4:40 PM ET
- Size
- 5.8 KB